Core 2b Huntington's Disease - Driving Biological Project

$205,361U54FY2012EBNIH

Brigham And Women'S Hospital, Boston MA

Investigators

Linked publications & trials

Paper 38383768 Paper 38204321 Paper 37742646 Paper 37168581 Paper 33549320 Paper 32276067 Paper 32216636 Paper 32023501 Paper 31254329 Paper 30756466 Paper 30381780 Paper 30368980 Paper 29994670 Paper 29973975 Paper 29617515 Paper 29560900 Paper 29492184 Paper 29291661 Paper 29129964 Paper 29092950 Paper 29051745 Paper 28966430 Paper 28763065 Paper 28664197 Paper 28626844 Paper 28593030 Paper 28582702 Paper 28399476 Paper 28392490 Paper 28316772 Paper 28295208 Paper 28202961 Paper 28119564 Paper 28113224 Paper 28092517 Paper 28090247 Paper 27840231 Paper 27818606 Paper 27747508 Paper 27747507 Paper 27739634 Paper 27688597 Paper 27654039 Paper 27498015 Paper 27354838 Paper 27344938 Paper 27336366 Paper 27254086 Paper 27253222 Paper 27131246 Paper 27065111 Paper 27061414 Paper 26963609 Paper 26941639 Paper 26900738 Paper 26897601 Paper 26889498 Paper 26886973 Paper 26870629 Paper 26791945 Paper 26761731 Paper 26646417 Paper 26599702 Paper 26527844 Paper 26521755 Paper 26490257 Paper 26372117 Paper 26339203 Paper 26277547 Paper 26259925 Paper 26257500 Paper 26257499 Paper 26236182 Paper 26221713 Paper 26221677 Paper 26221665 Paper 26179962 Paper 26143202 Paper 26140013 Paper 26112607 Paper 26101457 Paper 26090522 Paper 26089584 Paper 26082947 Paper 26082678 Paper 26082677 Paper 26082607 Paper 26068202 Paper 26037056 Paper 26029473 Paper 26028993 Paper 26028803 Paper 26028802 Paper 26028801 Paper 25937563 Paper 25859213 Paper 25820773 Paper 25721296 Paper 25717477 Paper 25664349

Abstract

The multi-site PREDICT-HD consortium led by the University of lowa on eariy detection of Huntington's Disease (HD) uses multimodal image, genetic, and clinical data from a large population to formulate and test hypotheses about the evolution of chronic diseases in at-risk individuals. Eariy intervention with implantable drug delivery devices could revolutionize the treatment of HD, but there are attendant risks. The statistical models that result from the application of customized image analysis to the PREDICT-HD cohort will provide a basis for conducting clinical pharmaceutical trials with increased sensitivity both to improvements and adverse outcomes.

View original record on NIH RePORTER →